Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SC5DL |
| Upstream (Parents) |
|---|
| (<<) NNT → SC5DL |
| (<<) SLC27A2 → SC5DL |
| (<<) SUCLG2 → SC5DL |
| (<<) GLUD1 → SC5DL |
| (<<) LMAN1 → SC5DL |
| (<<) C21orf33 → SC5DL |
| Downstream (Children) |
|---|
| SC5DL → PAICS (>>) |
| SC5DL → WDFY3 (>>) |
| SC5DL → PI4K2A (>>) |
| SC5DL → HSD3B2 (>>) |
| SC5DL → CABP1 (>>) |
| SC5DL → SUCLG2 (>>) |
| SC5DL → PTPRJ (>>) |
| SC5DL → ZXDB (>>) |
| SC5DL → RAB40AL (>>) |
| SC5DL → PTENP1 (>>) |
| SC5DL → THNSL2 (>>) |
| SC5DL → IL7 (>>) |
| SC5DL → MVK (>>) |
| SC5DL → HMGCS1 (>>) |
